The purpose of this study is to compare the safety and efficacy of letermovir with valganciclovir for prevention of Cytomegalovirus (CMV) viremia in moderate t…

CMV ViremiaHeart Transplant InfectionHeart Transplant Failure and Rejection

~Estimated

~$10 – $6,250

Columbia UniversityNCT07079735

Phase 4

Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients

The study is an interventional, non-randomized assessment of safety and efficacy of live Measles, Mumps and Rubella (MMR) vaccine in subjects aged 12-months to…

Heart Transplant Infection Prevention

~Estimated

~$10 – $6,250

Children's Mercy Hospital Kansas CityNCT07195032

Phase 1

Levothyroxine Supplementation for Heart Transplant Recipients: A Randomized Control Trial

This will be a prospective, randomized study performed at a single tertiary referral academic medical center (University of California San Francisco, CA), eval…

Heart Transplant FailureHeart Transplant Infection

~Estimated

~$10 – $5,625

University of California, San FranciscoNCT06428097